PIONEER Study of Lifestyle Intervention to Reduced Breast Cancer Risk

NCT ID: NCT04574063

Last Updated: 2023-01-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

240 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-16

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A randomised controlled trial in which women discharged from the symptomatic breast clinic, who are above population risk (according to Tyrer Cuzick) will be asked to create lifestyle related goals. They will be told their estimated risk of developing breast cancer and will be randomised to one of three interventions:

* Breast cancer risk leaflet only
* lifestyle website
* lifestyle website plus group coaching.

Fifty per cent of women will also be randomised to have Single Nucleotide Polymorphisms (SNPs) performed, and these will be incorporated into their risk score.

The primary end point will be whether or not women achieve their lifestyle goal.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Lifestyle Risk Reduction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Breast cancer risk leaflet only

Group Type NO_INTERVENTION

No interventions assigned to this group

Breast cancer risk leaflet PLUS SNPs

Group Type NO_INTERVENTION

No interventions assigned to this group

Lifestyle website only

Group Type EXPERIMENTAL

Lifestyle intervention to reduce breast cancer risk

Intervention Type BEHAVIORAL

Women will be educated about lifestyle factors which increase breast cancer risk. They will also be guided through an online goal setting process.

Lifestyle website PLUS SNPs

Group Type EXPERIMENTAL

Lifestyle intervention to reduce breast cancer risk

Intervention Type BEHAVIORAL

Women will be educated about lifestyle factors which increase breast cancer risk. They will also be guided through an online goal setting process.

Lifestyle website PLUS group coaching

Group Type EXPERIMENTAL

Lifestyle intervention to reduce breast cancer risk

Intervention Type BEHAVIORAL

Women will be educated about lifestyle factors which increase breast cancer risk. They will also be guided through an online goal setting process.

Lifestyle website PLUS group coaching PLUS SNPs

Group Type EXPERIMENTAL

Lifestyle intervention to reduce breast cancer risk

Intervention Type BEHAVIORAL

Women will be educated about lifestyle factors which increase breast cancer risk. They will also be guided through an online goal setting process.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lifestyle intervention to reduce breast cancer risk

Women will be educated about lifestyle factors which increase breast cancer risk. They will also be guided through an online goal setting process.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female
* Aged between 30 and 60 years
* Attending the symptomatic breast clinic at RMH Sutton or Chelsea OR the family history clinics at RMH Sutton or Chelsea, or has heard about the study through other means such as (but not limited to), friends who have been diagnosed with cancer, friends who are already taking part in the PIONEER study, social media, mainstream media, fliers through the doors of houses in the area of RMH.
* Benign or B3 diagnosis if participant has attended clinic
* Agree to receive their personalised breast cancer risk
* Available to participate in a 1 year risk prevention programme
* Able to attend the Royal Marsden for a blood test if randomised to this group

Exclusion Criteria

* Malignant Diagnosis
* Does not want to find out personalised breast cancer risk
* Not available to participate for the full year
* NOTE: after risk assessment, women who have a breast cancer risk lower than that of population level will be excluded from participating in the behavioural change elements.
Minimum Eligible Age

30 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute for Health Research, United Kingdom

OTHER_GOV

Sponsor Role collaborator

Royal Marsden NHS Foundation Trust

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jennifer Rusby

Role: PRINCIPAL_INVESTIGATOR

The Royal Marsden Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Royal Marsden Hospital NHS Foundation Trust

Sutton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Law R, Krupa K, Rusby J. Preventative therapy for breast cancer: a clinical experience. Breast Cancer Res Treat. 2023 Sep;201(2):205-213. doi: 10.1007/s10549-023-06985-1. Epub 2023 Jun 19.

Reference Type DERIVED
PMID: 37336835 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CCR 5113

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Rx for Better Breast Health
NCT02279303 COMPLETED NA
Breast Cancer Prevention Education
NCT01299623 COMPLETED NA
Personalized Breast Cancer Screening
NCT06060938 ACTIVE_NOT_RECRUITING NA